Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brachytherapy (Interventional Radiotherapy) for Squamous Cell Carcinomas of the Nasal Vestibule: Optimization of Dose and Technique A Multicenter Prospective Registration Study Endorsed by HNS GEC-ESTRO WG

NCT07801690 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT07801690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07801690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brachytherapy (Interventional Radiotherapy) for Squamous Cell Carcinomas of the Nasal Vestibule: Optimization of Dose and Technique A Multicenter Prospective Registration Study Endorsed by HNS GEC-ESTRO WG
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 31, 2034
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma nasal vestibule